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Abstract
Purpose To explore the prevalence and clinical features,
especially the reproductive function, of 45,X mosaicism
patients in northeast China.
Methods GTG-banding was performed on a series of 2,250
patients from our genetic counseling clinic. Each of these
patients underwent a physical examination and was inter-
viewed about their medical history and reproductive prob-
lems. Literature on 45,X mosaicism was accessed using
PubMed and reviewed.
Results The prevalence of 45,X mosaicism in northeast
China is 0.36 % (8/2250), and the mosaic karyotype of our
study accounted for 61.54 % (8/13) of Turner syndrome
cases. This is comparable with studies from Asia, Europe,
South America and other regions. The affected patients
showed genital abnormalities, abnormal pregnancy or
infertility.
Conclusion 45,X mosaicism is commonly seen in the ge-
netic counseling clinic. Extensive cytogenetic assessment
may improve the detection rate in patients with congenital
dysplasia, or history of abnormal pregnancy or infertility.
Karyotyping plays a key role in prognosis and assisted
reproduction or early surgical treatment.
Keywords Karyotype analysis . Turner’s syndrome . 45,X
mosaicism . Assisted reproduction
Introduction
Turner’s syndrome (TS) is characterized by a complete or
partial absence of one X chromosome. Patients have a range
of physical and skeletal features, in which final height and
gonadal function are almost always affected. The disorder is
thought to be caused by a haploinsufficiency of the escape
genes [1] as the X chromosome is enriched for genes
expressed in the brain, skeletal muscle, and in sex and
reproduction-related tissues [2]. The first documented case
of probable TS was amenorrhea in seven adolescent and
young adult females with sexual infantilism, short stature, a
webbed neck and cubitus valgus [3]. Since then, a number
of other karyotype anomalies, such as mosaicisms and struc-
tural anomalies of the second X chromosome, have been
found in association with TS.
Monosomy X (45,X) represents half of the karyotype spec-
trum of this syndrome, and the remainder includes structural X
chromosome abnormalities or mosaicism for a cell line con-
taining a second sex chromosome [4]. Fewer than 15 % of TS
patients appear to have mosaicism with a 46,XY cell popula-
tion or a Y chromosome rearrangement, 30–50 % are mosaic
with a second X or a structurally abnormal X [5], while X/XX
andX/XYindividuals make up 15.5% and 9.0%, respectively,
of TS patients [6]. Homer et al. [7] reported the frequency
of 45,X/46,XX mosaicism to be 9.6 %, compared with
an estimated 3.5 % of 45,X/46,XX in the overall female
population by Peschka et al. [8].
Many of the TS cases previously described are charac-
terized by variable phenotypes. Abnormalities in TS include
short stature (95–100 %), primary amenorrhea (85 %), in-
fertility (98 %), and characteristic stigmata [9]. In such
cases, growth hormone therapy should be started at the age
of 2–5, while hormone replacement therapy for the devel-
opment of normal female sexual characteristics should begin
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between 12 and 15 years of age and be continued long-term
to prevent the development of coronary artery disease and
osteoporosis. Affected women also need to undergo ge-
netic counseling prior to conception, followed by prenatal
assessment. Moreover, TS patients with a Y or Y-derived
chromosome have a 15 % increased risk of developing
gonadoblastoma [10].
45,X mosaicism is commonly seen during clinical diagno-
sis or genetic counseling, and has multiple phenotypes. Ocal et
al. [11] reported 11 cases (six females and five males) with
ambiguous genitalia and/or delayed puberty with or without
short stature. A study in the United States of nine females and
seven males aged 15–17 years showed that while all had
Müllerian structures (uterus and fallopian tubes), three girls
had bilateral streak testes/gonads, nine children (six girls and
three boys) had unilateral testes and contralateral streak testes/
gonads, and four boys had bilateral testes, with signs of
decreased virilization in one but normal male genitalia in the
remaining three [12]. About 10–15 % of 45,X/46,XX patients
have been reported to menstruate, some have follicles in their
ovarian cortical tissue during adolescence, while some
patients with a non-mosaic 45,X karyotype have even been
reported to become pregnant [13].
Exploring ways to optimize the ovarian potential of TS
patients is an area of ongoing interest that includes in vitro
fertilization (IVF) and oocyte cryopreservation [14–16].
However, data suggest that even when pregnancy is spon-
taneously achieved in TS-Mosaic women, there is a marked
increase in adverse outcomes. These concerns coupled with
the inherently poor ovarian reserve in TS and TS-Mosaic
patients have led to the emergence of donor oocyte IVF as a
viable treatment option for patients. However, Brezina [17]
showed that the rate of maternal X chromosome mosaicism
does not affect pregnancy loss rates in TS-Mosaic women
undergoing donor oocyte IVF.
Our study focused on the prevalence of 45,X mosaicism
in patients from northeast China. To our knowledge, it is the
first to evaluate this together with congenital dysplasia,
histories of abnormal pregnancy or infertility and different
clinical features on reproduction.
Materials and methods
Patients
Between August 2010 and June 2012, 2,250 TS cases aged
between 18 and 39 years with congenital dysplasia and
histories of abnormal pregnancy or infertility were collected
from our genetic counseling clinic. Each patient underwent
a physical examination and was interviewed about their
medical histories and reproductive problems.
Semen analysis
Semen samples were obtained after a 5–7 day period of
ejaculatory abstinence, and semen analysis was performed
according to World Health Organization guidelines [18].
Semen parameters were assessed by using computer-
assisted semen analysis (CASA). Each patient underwent
semen analysis at least twice before a diagnosis of non-
obstructive azoospermia or oligozoospermia was made.
Patients with obstructive azoospermia were excluded from
this study.
Cytogenetic studies
Cytogenetic studies were performed using G-banding in
peripheral blood lymphocytes according to standard techni-
ques [19]. Briefly, peripheral blood lymphocytes were cul-
tured for 72 h in RPMI medium 1640 (GIBCO, Invitrogen,
Carlsbad, CA, USA) and fetal bovine serum (Beijing Ding-
guo Biotechnology, Beijing, China) containing phytohe-
magglutinin (Shang-hai Yihua Medical Technology Co.,
Ltd., Shanghai, China), treated with 50 μg/ml colcemid
for 1 h, then harvested for analysis. G-banding of meta-
phase chromosomes was performed by Giemsa staining.
At least 20 metaphase cells were analyzed per patient.
The procedure was repeated in all cases with abnormal
karyotypes. Chromosomal abnormalities were described
according to the International System for Human Cyto-
genetic Nomenclature.
Table 1 Patient phenotypes and
karyotype frequencies SN Age(years) Sex Karyotype Phenotype
1 18 Female 45,X[14]/ 46,XX[36] No menses
2 39 Female 45,X[36]/47,XXX[14] Embryonic diapause
3 21 Female 47,XXX[31] /45,X[5]/46,XX[14] Preparation for IVF treatment
4 26 Male 46,X,dic(Y)(p11)[47] /45,X[13] Azoospermia
5 25 Male 45,X [18]/48,XYYY [12] Azoospermia
6 25 Male 45,X[29]/46,XY[21] Azoospermia
7 23 Male 45,X[30] /46,XY[20] Azoospermia
8 25 Male 45,X[6]/46,XY[24] Oligospermia
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Results
Of the 2,250 patients with congenital dysplasia, abnormal
pregnancy history or infertility, 13 cases had 45,X or 45,
X mosaicism and eight had 45,X mosaicism, giving a
prevalence of 0.36 % (8/2,250) and accounting for
61.54 % (8/13) of TS patients, respectively. Of these
eight patients, 37.5 % (3/8) were mosaic with a second
X or X trisomy, with no structurally abnormal X chro-
mosome. Five of the eight patients (62.5 %) had mosa-
icism with a 46,XY cell population or a Y chromosome
rearrangement (Table 1).
There were three female cases of 45,X mosaicism; one was
amenorrheic, the second had experienced embryonic diapause
twice, while the third with 45,X [5]/ 47,XXX [31] /46,XX
[14] was receiving IVF treatment. The remaining five male
Table 2 Comparison of karyotypes, prevalence and phenotypes between different populations
Area Population Phenotype Karyotype Prevalence
Southeast
Asia




Recurrent spontaneous abortion 45,X/46,XX/47,XXX 77.78 % (14/
18)
45,X/46,XX 25 % (2/18)
Indonesia(2011)[38] Turner syndrome 45,X/46,XY 3.2 % (3/95)
Japan(1997) [28] Azoospermia, maturation arrest of the
primary spermatocyte
46,X,dic(Y)[33] /45,X[7] –
China(2011) [35] Disorders of sex development, 2 cryptorchidism,
1 immature uterus, 1 had testicular dysgenesis
and 1 normal testis.
45,X/46,XY –
The current study No menses 45,X[14] /46,XX[36] 7.69 % (1/13)
Embryonic diapause 45,X[36]/47,XXX[14] 7.69 % (1/13)
Oligospermia/ Azoospermia 45,X/46,XY 23.08(3/13)
Middle East
Asia
Israel(2001)[34] Spontaneous abortion 45,X/46,XX 15 %
Europe Turkey(2012)[11] Sex chromosome DSD 45,X/46,XY 3.9 % (11/285)
Turkey(2009)[39] Azoospermia 45,XO/46,XY 1.16 % (1/86)
France(2010)[21] Reproductive medicine clinics 45,X/46,XX 9.6 %
France(2012)[7] Premature ovarian failure, or recurrent
spontaneous abortions
45,X/46,XX(6–28 % of aneuploidy) –
France (2010)[21] Body mass index was increased from 6 % of aneuploidy
and menarche occurred earlier from 10 % of aneuploidy
45,X/46,XX(4 to 28 % of
aneuploidy)
–
Italy(2001) [25] Secondary amenorrhea, weight loss
and streak-like ovaries
45,X[90 %]/47,XXX[10 %] –
Greece(2011)[26] Short stature, had two successful pregnancies 45,X/47,XXX –
Spain (2012)[29] Primary amenorrhea and hirsutism, congenital adrenal
hyperplasia
46,X,dic(Y)[70 %]/45,X[30 %] –
UK(2012)[30] Mixed gonadal dysgenesis(MGD).
Early surgical management
45,X /47,XYY –
Turkey(2010)[34] Azoospermia, Sperm could be obtained
from testicular sperm extraction (TESE)
45,X[5 %]/46,XY[95 %] –
Turkey(2010)[34] Severe oligozoospermia 45,X[20 %]/46,XY[80 %] –
Turkey(2010)[34] Severe oligozoospermia, NO any spermatozoa by TESE 45,X[45 %]/46,XY[55 %] –
Switzerland
(2007)[33]
Turner syndrome, short stature, mixed gonadal dysgenesis 45,X[25 %]/46,XY[75 %] –
Italy(2006)[32] Bilateral breast cancer, ambiguous external genitalia 45,X/46,XY –
Turkey(2012)[11] Ambiguous genitalia and/or delayed puberty with or
without short stature.
45,X/46,XY –
North America USA(2010) [22] Menstrual periods were irregular, spontaneous pubertal
development with menarche
45,X[45 %]/46,XX[55 %] –
Mexico(2009)[36] Primary infertility, short stature, and hypothyroidism, a
bicornuate uteru
45,X/47,XXX/46,XX –
USA(2012) [12] Three female bilateral streak testis/gonad. Nine children
(six reared female and three male) unilateral testis and
contralateral streak testis/gonad, Four male bilateral
testes.
45,X/46,XY –
South America Venezuela(2003)[37] Turner syndrome 45,X/46,XX;45,X/47,XXX /46,XX 17 %
45,X/46,XY 4 %
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cases with 45,X monoploidy were azoospermic or oligozoo-
spermic (Table 1).
Discussion
The prevalence of 45,X mosaicism in current TS research
differs according to population, but the range is relatively
stable. A previous study found a 45,X/46,XX mosaicism fre-
quency of approximately 15 % in TS patients [6], while Kuo
[20] reported a 45,X/46,XX mosaicism incidence rate of 25 %
in repeated spontaneous abortion patients. In the present study,
there were three females with 45,X mosaicism (Table 1), and
the prevalence of karyotype 45,X/46,XX or 45,X/47,XXX/46,
XX in our study was only slightly lower than in other reported
Asian regions (Table 2). Although our prevalence of 45, X/46,
XY mosaicism (Fig. 1) was higher than in most other regions,
it is comparable with a study by Kannan [6] (Table 2).
It has previously been reported that patients with 6–28 %
aneuploidy and 45,X/46,XX mosaicism showed the clinical
manifestations of premature ovarian failure or recurrent spon-
taneous abortions. However, the extent of these symptoms
appears to have no adverse effect on the outcomes of IVF or
intracytoplasmic sperm injection (ICSI) [7]. Patients with more
than 6 % aneuploidy often have an increased body mass index
[21], and Oktay et al. [22] reported on one such patient with
karyotype 45,X [45 %]/46,XX [55 %], a large proportion of
aneuploidy and irregular menstrual periods. The study con-
cluded that controlled ovarian stimulation and oocyte cryopres-
ervation may be an option for fertility preservation in selected
adolescents with TS mosaicism and impending ovarian failure.
Triple X (47,XXX) females occur in approximately
1/1,000 females and have no recognized characteristic pheno-
type. They do, however, show a significantly elevated mor-
tality with a standardized mortality ratio of 2.5 or an
approximately 7-year shortened lifespan [23]. We observed
one case of a 39-year-old 45,X [72 %]/47, XXX [28 %]
female who twice experienced embryonic diapause in the
present study. Other similar cases include a 45,X [90 %]/47,
XXX [10 %] patient with secondary amenorrhea, weight loss
and streak-like ovaries [24]. However, one 45,X/47,XXX case
has reported to achieve two successful pregnancies [25, 26].
One male case of 46,X,dic(Y) [78 %]/45,X [22 %] in the
present study was azoospermic, which is comparable with
frequencies in a similar Japanese study [27]. In addition,
García Benítez et al. [28] reported one female patient with
30 % aneuploidy (46,X, dic(Y) [70 %]/45,X [30 %]) with
clinical features of primary amenorrhea and congenital adre-
nal hyperplasia. Compared with our study, these abnormalities
may relate to the proportion of aneuploidy. Another previous
study reported three cases of 45,X /47,XYY (one male and
two females) with mixed gonadal dysgenesis (MGD) [29].
The prenatal diagnosis of 45,X/46,XY mosaicism occurs
in approximately 1.7 per 10,000 prenatal samples. The
phenotype ranges from 90 % of normal male fetuses to
postnatal features that include a wide spectrum of pheno-
types such as hypospadias [30]. Affected males can benefit
from assisted reproductive therapies, but prenatal diagnosis
plays an important role in preventing the transmission of
genetic abnormalities [31, 32]. Kilic et al. [33] reported on
three cases with different degrees of 45,X monoploidy,
which compares with the three cases in our own study:
two with 45,X [60 %]/46,XY [40 %] and 45,X [58 %]/46,
XY [42 %] were azoospermic while the third with 45,X [6]/
46,XY [26] was oligospermic (Table 2).
Thus, the 45,X mosaicism karyotype has obvious effects
on reproduction. As the proportion of aneuploidy is much
larger, it may lead to more serious results such as azoosper-
mia and severe oligospermia. However, there is no obvious
relationship between the percentage of mosaicism (the
Fig. 1 GTG-banding on karyotype 45,X/46,XY. (a) karyotype 46,XY. (b) karyotype 45,X
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number of 45,X cells relative to the total number of cells)
and the presence or degree of abnormalities, suggesting that
mosaicism is not the only cause of these.
In conclusion, the occurrence of 45,X mosaicism makes it
necessary to undertake chromosome karyotype analysis in
patients suffering from fertility problems or with obvious
abnormal symptoms. Accurate diagnosis can provide infor-
mation and evidence for assisted reproduction or early surgi-
cal treatment.
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